Calcium Acetate NDC 0615-8632

NDC codes

FDA NDC Directory

Product NDC (as listed)0615-8632Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00615-8632Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0615-8632-39	00615863239	30 CAPSULE in 1 BLISTER PACK (0615-8632-39)Marketed from Apr 16, 2026

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Calcium Acetate
Generic name (nonproprietary): calcium acetate
Active ingredients: Calcium acetate — 667 mg/1
Dosage form: Capsule
Route: Oral
Labeler: NCS HealthCare of KY, LLC dba Vangard Labs
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217205
Marketing start: Dec 7, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Phosphate Chelating Activity (Mechanism)
Identifiers: Product ID 0615-8632_fddc4c24-ba97-4314-869b-10cc900be047SPL ID fddc4c24-ba97-4314-869b-10cc900be047SPL set ID 7177829c-bd89-485c-b5e3-15e457e969c5RxCUI 359296UNII Y882YXF34X
Pharmacologic class: Blood Coagulation Factor; Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400615863239 followed by a unit qualifier and the quantity

Package 00615-8632-39. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 17, 2026.

Indications (excerpt from the label)

Calcium acetate capsules are a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). • Calcium acetate capsules are a phosphate binder indicated for the reduction of serum phosphorus in patients with end stage renal disease.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 217205

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217205
Product	Strength	Form · route	Labeler	Product NDC
Calcium Acetate	Calcium acetate 667 mg/1	CapsuleOral	SQUARE PHARMACEUTICALS LIMITED	76483-086
Calcium Acetate	Calcium acetate 667 mg/1	CapsuleOral	Nivagen Pharmaceuticals, Inc.	75834-323
Calcium Acetate	Calcium acetate 667 mg/1	CapsuleOral	PD-Rx Pharmaceuticals, Inc.	72789-422